Neuera Wellness Announces Launch of 503A GLP-1 Telehealth Program
- Kevin Seely

- Jul 5
- 2 min read
New telehealth program expands access to provider-guided metabolic health support through licensed medical evaluation and patient-specific pharmacy fulfillment
Pompano Beach, Florida — July 20th, 2026 — Neuera Wellness today announced the launch of its 503A GLP-1 telehealth program, designed to help eligible patients access provider-guided metabolic health support through a convenient, compliant, and patient-centered digital care model.
The new program connects individuals with licensed healthcare providers who review patient intake information, medical history, treatment goals, and eligibility criteria to determine whether GLP-1 therapy may be appropriate. When clinically indicated and legally available, prescriptions may be fulfilled through a qualified 503A pharmacy pursuant to a patient-specific prescription.
“At Neuera Wellness, we believe access, education, and responsible care are essential parts of the wellness journey,” said Kevin Seely, Chief Operating Officer of Neuera Wellness. “You can’t put a price tag on health. My team and I think health and wellness is more than the body. It’s also about the mind.”
The Neuera Wellness GLP-1 telehealth program was developed to provide a structured experience that includes secure digital intake, provider review, pharmacy coordination where applicable, and ongoing support resources. The program is intended for individuals seeking a guided approach to metabolic wellness, weight management support, and healthier lifestyle alignment under the direction of licensed healthcare professionals.
“People are looking for more than a product,” Seely added. “They want clarity, support, accountability, and a trusted process. Our goal is to make the experience easier to understand while keeping medical decision-making where it belongs — with licensed providers.”
Neuera Wellness emphasizes that treatment is not guaranteed. All prescription decisions are made solely by licensed healthcare providers based on each patient’s individual health profile, medical necessity, applicable law, and clinical judgment. Patients must complete required intake documentation before provider review can occur.
Compounded medications, when prescribed, are prepared for individual patients by a pharmacy pursuant to a valid prescription. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before being marketed. Individual results may vary, and no outcome is guaranteed.
The launch reflects Neuera Wellness’s broader mission to support health-conscious individuals through accessible, responsible, and education-driven wellness solutions.
For more information about Neuera Wellness and its GLP-1 telehealth program, visit www.neuerawellness.com.
About Neuera Wellness
Neuera Wellness is a health and wellness company focused on helping individuals take a more informed, proactive approach to their wellness journey. Through secure digital tools, provider-connected services, and patient-centered support, Neuera Wellness aims to make modern wellness solutions more accessible, transparent, and guided by qualified professionals.
Media Contact
Neuera Wellness
Attn: Media Relations
Email: media@neuerawellness.com
Phone:
Website: www.neuerawellness.com
Important Medical Disclaimer
Neuera Wellness does not provide emergency medical care. If you are experiencing a medical emergency, call 911 or seek immediate medical attention. Information provided by Neuera Wellness is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Prescription products are available only when determined appropriate by a licensed healthcare provider. Individual results may vary.

Comments